Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Biosafe Affirms its Leadership in India

September 23, 2013

EYSINS, Switzerland, September 23, 2013 /PRNewswire/ –

Biosafe is pleased to announce that, in partnership with its Indian Distributor Span
Healthcare Private Ltd., it has achieved major expansion of its stem cell banking business
in India, winning major new customer deals consecutively.

In the public stem cell banking area, Jeevan Blood Bank and Research Centre in Chennai
is expanding its program and will process its full volume of stem cell samples with
Biosafe’s proprietary Sepax cell separation system and Coolmix cryo-preparation cooling
and mixing device.

On the family banking side, the renowned companies Cordlife India and Cryobanks
International are likewise moving to automated processing exclusively by Sepax.

Such expansion is a milestone as the majority of cord blood samples in India will now
be processed with Biosafe technology.

Olivier Waridel, CEO of the Biosafe Group, commented: “These recent wins illustrate
the potential of Biosafe’s Sepax technology in the BRIC economies. Biosafe demonstrates
its ability to meet customer expectations through its vast portfolio of processing
solutions and is committed to further support stem cell banking expansion in India
together with Span Healthcare”.

About the Biosafe Group

Founded in 1997 the Biosafe Group is active in the design, manufacture and marketing
of automated cell processing systems. Headquartered in Switzerland and privately-owned,
the Biosafe Group operates through regional subsidiaries (Geneva, Houston, Hong-Kong,
Shanghai and Sao Paulo) and is present in more than 45 countries, either directly or
through distributors.

        For further information:

        Christopher Bolton
        CFO
        Biosafe Group
        +41-22-365-27-27
        christopher.bolton@biosafe.ch

http://www.biosafe.ch

SOURCE Biosafe Group


Source: PR Newswire